Literature DB >> 30022299

Hematological malignancies mimicking rheumatic syndromes: case series and review of the literature.

Gil Bornstein1,2, Nadav Furie3,2, Nimrod Perel3,2, Ilan Ben-Zvi3,4,2, Chagai Grossman5,6,7.   

Abstract

It is well established that some rheumatic syndromes (RS) are associated with several hematological malignancies. We aimed to describe the clinical course of patients with hematological malignancies mimicking RS. We studied a series of four patients presenting with apparent RS who were eventually diagnosed with hematological malignancies, and reviewed the relevant literature. Our series consisted of 4 patients, with a mean age of 62.8 ± 20.3 years, who presented to our rheumatology unit between December 2012 and March 2018. Two patients were initially diagnosed with polyarthritis. One of these patients was eventually diagnosed with multiple myeloma and amyloidosis and the other was diagnosed with angioimmunoblastic T-cell lymphoma. The third patient was initially diagnosed with migratory arthritis and was eventually diagnosed with acute myeloid leukemia. The fourth patient was initially diagnosed with giant cell arteritis and eventually diagnosed with anaplastic large T-cell lymphoma. All the patients displayed a very good response to corticosteroid treatment. Vigilance for occult malignancy is essential in the diagnostic workup of RS. A good response to corticosteroids may constitute a major diagnostic pitfall in patients with hematological malignancies presenting with an apparent RS. In these cases, subtle clinical and laboratory features should elicit the clinician to seek for an occult malignancy.

Entities:  

Keywords:  Hematological malignancies; Rheumatic syndromes

Mesh:

Year:  2018        PMID: 30022299     DOI: 10.1007/s00296-018-4107-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  45 in total

1.  Woody hands.

Authors:  A B Alexandroff; B L Hazleman; M Matthewson; C M Black; E Rytina; R Crawford; N P Burrows
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

Review 2.  Malignancies and soluble tumor antigens in rheumatic diseases.

Authors:  Eva Szekanecz; Csilla András; Zsuzsa Sándor; Péter Antal-Szalmás; János Szántó; László Tamási; Emese Kiss; Zoltán Szekanecz
Journal:  Autoimmun Rev       Date:  2006-04-19       Impact factor: 9.754

Review 3.  RS3PE revisited: a systematic review and meta-analysis of 331 cases.

Authors:  Paras Karmacharya; Anthony A Donato; Madan R Aryal; Sushil Ghimire; Ranjan Pathak; Kalpana Shah; Pragya Shrestha; Dilli Poudel; Thomas Wasser; Ananta Subedi; Smith Giri; Leena Jalota; Alejandro Olivé
Journal:  Clin Exp Rheumatol       Date:  2016-03-25       Impact factor: 4.473

4.  Association of the autoimmune disease scleroderma with an immunologic response to cancer.

Authors:  Christine G Joseph; Erika Darrah; Ami A Shah; Andrew D Skora; Livia A Casciola-Rosen; Fredrick M Wigley; Francesco Boin; Andrea Fava; Chris Thoburn; Isaac Kinde; Yuchen Jiao; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Antony Rosen
Journal:  Science       Date:  2013-12-05       Impact factor: 47.728

5.  Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome.

Authors:  D J McCarty; J D O'Duffy; L Pearson; J B Hunter
Journal:  JAMA       Date:  1985-11-15       Impact factor: 56.272

Review 6.  Clonal diseases of large granular lymphocytes.

Authors:  T P Loughran
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

Review 7.  Autonomic paraneoplastic neurological syndromes.

Authors:  Lorenzo Lorusso; Ian K Hart; Daniela Ferrari; Gaelle K Ngonga; Chiara Gasparetto; Giovanni Ricevuti
Journal:  Autoimmun Rev       Date:  2006-11-17       Impact factor: 9.754

8.  Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia.

Authors:  T Shirota; O Hayashi; H Uchida; N Tonozuka; N Sakai; H Itoh
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

9.  Amyloid arthropathy in the course of multiple myeloma.

Authors:  Bruno Fautrel; Jean-Paul Fermand; Jean Sibilia; Dominique Nochy; Benoît Rousselin; Philippe Ravaud
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

10.  Incidence of cancer among patients with rheumatoid arthritis.

Authors:  G Gridley; J K McLaughlin; A Ekbom; L Klareskog; H O Adami; D G Hacker; R Hoover; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1993-02-17       Impact factor: 13.506

View more
  2 in total

1.  Indications for bone marrow examinations in rheumatology.

Authors:  Hava Üsküdar Teke; Döndü Üsküdar Cansu; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2019-04-30       Impact factor: 2.631

2.  A Case of Multiple Myeloma Misdiagnosed as Seronegative Rheumatoid Arthritis and Review of Relevant Literature.

Authors:  Scott Schoninger; Yamen Homsi; Alexandra Kreps; Natasa Milojkvovic
Journal:  Case Rep Rheumatol       Date:  2018-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.